

The weak evidence behind Trump’s autism announcement
22 snips Sep 23, 2025
The podcast dives into Trump’s controversial claims regarding autism treatment, highlighting shaky evidence behind new regulations. It also examines a proposed $100,000 fee for H-1B visas and its potential impact on skilled foreign workers. A gripping story unfolds about a man saved from an organ harvesting mishap, raising concerns about the transplant industry. Additionally, there’s news about Jimmy Kimmel's return, a major NVIDIA-OpenAI deal, and how Build-A-Bear is capitalizing on nostalgia in the stock market.
AI Snips
Chapters
Transcript
Episode notes
Weak Evidence Behind Acetaminophen Claim
- The White House warned against acetaminophen in pregnancy despite no proven causal link to autism.
- Researchers and medical experts say evidence is thin and more study is needed before broad guidance changes.
Talk To Your Doctor About Pain Relief
- Pregnant patients should consult their doctors before using acetaminophen and use low doses for short durations if needed.
- Avoid untreated fever or pain, since those also pose risks to pregnancy and fetal development.
Leucovorin Labeled Too Soon, Researchers Warn
- HHS plans to relabel leucovorin as an FDA-recognized therapy for cerebral folate deficiency tied to autism symptoms.
- Dan Diamond and researchers caution that early studies are small and it's too soon to call it a miracle treatment.